The COAPT study found the MitraClip® device is a viable option for treating patients with heart failure and moderate-to-severe mitral regurgitation.
COVID-19 Updates: Get the latest information on appointment scheduling and safety measures.
COVID-19 Updates: Get the latest information on appointment scheduling and safety measures.
The COAPT study found the MitraClip® device is a viable option for treating patients with heart failure and moderate-to-severe mitral regurgitation.